Molecular Endocrinology, Vol 8, 545-557, Copyright © 1994 by Endocrine Society

ARTICLES

Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone

MJ Saad, F Folli, E Araki, N Hashimoto, P Csermely and CR Kahn
Research Division Joslin Diabetes Center, Brigham and Women's Hospital, Boston, Massachusetts 02215.

Insulin rapidly stimulates tyrosine kinase activity of its receptor resulting in phosphorylation of its cytosolic substrate insulin receptor substrate 1 (IRS-1), which in turn associates with and activates the enzyme phosphatidylinositol 3-kinase (PI 3-kinase). In the present study we have examined these three initial steps in insulin action during the differentiation of 3T3-F442A adipocytes and after treatment with dexamethasone or insulin. The differentiation of 3T3- F442A cells was characterized by a 13-fold increase in insulin receptor protein, a 9-fold increase in IRS-1, and a 10- and 4.5-fold increase in their insulin-stimulated phosphorylation, respectively. The mRNA expression of these two proteins showed a similar 8-fold increase during differentiation. In addition there was a 3.5-fold increase in PI 3-kinase protein [85 kilodalton (kDa) subunit] and a 16-fold increase in IRS-1-associated PI 3-kinase activity between day 0 and day 8 of differentiation. Dexamethasone (1 microM) treatment of differentiated cells induced a further 48% (P < 0.05) increase in insulin receptor level, but the autophosphorylation of the receptor was decreased by 31 +/- 1% (P < 0.02). At the same time there was a decrease by 56 +/- 4% (P < 0.005) in IRS-1 protein and by 31 +/- 1% (P < 0.001) in IRS-1 phosphorylation. The expression of insulin receptor mRNA was unchanged, but the expression of IRS-1 mRNA was decreased by approximately 75% after dexamethasone. By contrast, dexamethasone induced a 69% increase in the level of PI 3-kinase as determined by immunoblotting. The combined effect of decreased IRS-1 phosphorylation and increased PI 3- kinase protein was a minimal change (15% decrease) in the association/activation between IRS-1 and PI 3-kinase. Chronic treatment with 100 nM insulin induced a time- and dose-dependent decrease in insulin receptor and IRS-1 protein levels reaching a nadir of 34 +/- 5% (P < 0.005) and 39 +/- 5% (P < 0.01) of control levels after 24 h, respectively. There was an even more marked decrease in the phosphorylation level of these proteins. Chronic insulin treatment also produced a 30% decrease in PI 3-kinase protein levels and a approximately 50% decrease in the association/activation between IRS- 1/PI 3-kinase. The expression of insulin receptor and IRS-1 mRNA was unchanged during chronic insulin treatment.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				W. L. Holland and S. A. Summers Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism Endocr. Rev., June 1, 2008; 29(4): 381 - 402. [Abstract] [Full Text] [PDF]

				M. Lowenberg, J. Tuynman, M. Scheffer, A. Verhaar, L. Vermeulen, S. van Deventer, D. Hommes, and M. Peppelenbosch Kinome Analysis Reveals Nongenomic Glucocorticoid Receptor-Dependent Inhibition of Insulin Signaling Endocrinology, July 1, 2006; 147(7): 3555 - 3562. [Abstract] [Full Text] [PDF]

				X. Li, P. A. Hansen, L. Xi, R. A. S. Chandraratna, and C. F. Burant Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor {gamma} and Retinoic Acid X Receptors J. Biol. Chem., November 18, 2005; 280(46): 38317 - 38327. [Abstract] [Full Text] [PDF]

				S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF]

				E. P. Araujo, C. T. De Souza, A. L. Gasparetti, M. Ueno, A. C. Boschero, M. J. A. Saad, and L. A. Velloso Short-Term in Vivo Inhibition of Insulin Receptor Substrate-1 Expression Leads to Insulin Resistance, Hyperinsulinemia, and Increased Adiposity Endocrinology, March 1, 2005; 146(3): 1428 - 1437. [Abstract] [Full Text] [PDF]

				D. P. Argentino, F. P. Dominici, K. Al-Regaiey, M. S. Bonkowski, A. Bartke, and D. Turyn Effects of Long-Term Caloric Restriction on Early Steps of the Insulin-Signaling System in Mouse Skeletal Muscle J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2005; 60(1): 28 - 34. [Abstract] [Full Text] [PDF]

				M. Lundgren, J. Buren, T. Ruge, T. Myrnas, and J. W. Eriksson Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2989 - 2997. [Abstract] [Full Text] [PDF]

				J. Shao, H. Yamashita, L. Qiao, B. Draznin, and J. E. Friedman Phosphatidylinositol 3-Kinase Redistribution Is Associated With Skeletal Muscle Insulin Resistance in Gestational Diabetes Mellitus Diabetes, January 1, 2002; 51(1): 19 - 29. [Abstract] [Full Text] [PDF]

				A. Kasus-Jacobi, D. Perdereau, C. Auzan, E. Clauser, E. Van Obberghen, F. Mauvais-Jarvis, J. Girard, and A.-F. Burnol Identification of the Rat Adapter Grb14 as an Inhibitor of Insulin Actions J. Biol. Chem., October 2, 1998; 273(40): 26026 - 26035. [Abstract] [Full Text] [PDF]

				A. Ptasznik, G. M. Beattie, M. I. Mally, V. Cirulli, A. Lopez, and A. Hayek Phosphatidylinositol 3-Kinase Is a Negative Regulator of Cellular Differentiation J. Cell Biol., June 2, 1997; 137(5): 1127 - 1136. [Abstract] [Full Text] [PDF]

				F. Giorgino, M. T. Pedrini, L. Matera, and R. J. Smith Specific Increase in p85alpha Expression in Response to Dexamethasone Is Associated with Inhibition of Insulin-like Growth Factor-I Stimulated Phosphatidylinositol 3-Kinase Activity in Cultured Muscle Cells J. Biol. Chem., March 14, 1997; 272(11): 7455 - 7463. [Abstract] [Full Text] [PDF]

				R. Burikhanov, K. Coulonval, I. Pirson, F. Lamy, J. E. Dumont, and P. P. Roger Thyrotropin via Cyclic AMP Induces Insulin Receptor Expression and Insulin Co-stimulation of Growth and Amplifies Insulin and Insulin-like Growth Factor Signaling Pathways in Dog Thyroid Epithelial Cells J. Biol. Chem., November 15, 1996; 271(46): 29400 - 29406. [Abstract] [Full Text] [PDF]

				S. Ugi, H. Maegawa, A. Kashiwagi, M. Adachi, J. M. Olefsky, and R. Kikkawa Expression of Dominant Negative Mutant SHPTP2 Attenuates Phosphatidylinositol 3`-Kinase Activity via Modulation of Phosphorylation of Insulin Receptor Substrate-1 J. Biol. Chem., May 24, 1996; 271(21): 12595 - 12602. [Abstract] [Full Text] [PDF]